AstraZeneca PLC provided earnings guidance for the fiscal year 2022. The company expects total revenue to increase by a high teens percentage and Core EPS is expected to increase by a mid-to-high twenties percentage.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,279 GBX | -0.74% | +1.49% | +16.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.02% | 240B | |
+29.52% | 684B | |
+30.07% | 568B | |
-4.01% | 361B | |
+18.28% | 329B | |
+4.61% | 284B | |
+9.53% | 208B | |
-6.79% | 200B | |
+8.25% | 166B | |
-0.80% | 159B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca PLC Provides Earnings Guidance for the Fiscal Year 2022